Advertisement

European Journal of Pediatrics

, Volume 177, Issue 6, pp 879–886 | Cite as

Advanced maternal age during pregnancy and the risk for malignant morbidity in the childhood

  • Majdi Imterat
  • Tamar Wainstock
  • Eyal Sheiner
  • Joseph Kapelushnik
  • Laura Fischer
  • Asnat Walfisch
Original Article

Abstract

In the past several decades, rates of delayed childbearing have increased, and as a result, maternal age has advanced. Our objective was to evaluate whether advanced maternal age is independently associated with an increased risk of childhood cancers in the offspring. A retrospective cohort study of women who delivered between the years 1991 and 2014 was conducted. Elderly parturients (≥ 35 years) were divided into two sub-categories: 35–39 and 40–50 years. The comparison group consisted of parturients aged 20–34 years. All hospitalizations of offspring up to the age of 18 years involving malignant morbidity were compared between the groups. A Kaplan-Meier survival curve was used to compare cumulative malignant morbidity incidence of the offspring. A Weibull regression model was used to control for confounders. During the study period, 201,738 deliveries met the inclusion criteria. Of them, 16.3% (n = 32,804) occurred in mothers aged 35 years or more (35–39 years old n = 26,145, 79.7%; 40–50 years old n = 6659, 20.3%). In the Weibull regression model, advanced maternal age exhibited no association with general malignant morbidity in the offspring up to 18 years of age (mothers aged 35–39: adjusted HR 1.06, 95% CI 0.76–1.48, p = 0.727; mothers aged 40–50: adjusted HR 0.73, 95% CI 0.36–1.46, p = 0.373). For leukemia, the regression model exhibited an independent association in maternal ages of 35–39 (adjusted HR 2.23, 95% CI 1.34–3.69, p = 0.002).

Conclusion: Advanced maternal age does not appear to raise the risk for future malignancy in the offspring up to the age 18 years. The specific nature of the association between maternal age and leukemia of the offspring necessitates further investigation.

What is Known:

• Advanced maternal age is associated with a marked elevation in the risk of different pregnancy complications and adverse pregnancy outcomes.

What is New:

Advanced maternal age does not appear to raise the risk for future malignancy in the offspring up to the age 18 years.

Leukemia of the offspring may be associated with advanced maternal age although the specific nature of the association necessitates further investigation.

Keywords

Follow-up Elderly Pediatric morbidity Cancer Leukemia Malignancy Offspring 

Notes

Authors’ contributions

Majdi Imterat: Protocol/project development, analysis interpretation, data management, writing of the first manuscript draft.

Tamar Wainstock: Data analysis, analysis interpretation, manuscript editing.

Eyal Sheiner: Protocol/project development, analysis interpretation, data management, manuscript editing.

Joseph Kapelushnik: Analysis interpretation, manuscript editing.

Laura Fischer: Analysis interpretation, manuscript editing.

Asnat Walfisch: Protocol/project development, analysis interpretation, data management, manuscript editing.

Funding

This study was not funded.

Compliance with ethical statement

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

For this type of study, formal consent is not required. This is a database retrospective study. This article does not contain any studies with human participants or animals performed by any of the authors.

Supplementary material

431_2018_3136_MOESM1_ESM.docx (29 kb)
ESM 1 (DOCX 29 kb)

References

  1. 1.
    Berkowitz GS, Skovron ML, Lapinski RH, Berkowitz RL (1990) Delayed childbearing and the outcome of pregnancy. N Engl J Med 322(10):659–664CrossRefPubMedGoogle Scholar
  2. 2.
    Centers for Disease Control and Prevention. (2007) Assisted reproductive technology success rates: National Summary and Fertility Clinic Reports. Centers for Disease Control and Prevention. American Society for Reproductive Medicine, Society for Assisted Reproductive TechnologyGoogle Scholar
  3. 3.
    Central Bureau of Statistics, Number of households in 2016, Israel 2016. Available from: http://cbs.gov.il/www/publications15/meshek_bait/households.pdf
  4. 4.
    Cleary-Goldman J, Malone FD, Vidaver J, Ball RH, Nyberg DA, Comstock CH, Timor-Tritsch IE (2005) Impact of maternal age on obstetric outcome. Obstet Gynecol 105(5, Part 1):983–990CrossRefPubMedGoogle Scholar
  5. 5.
    Dockerty JD, Draper G, Vincent T, Rowan SD, Bunch KJ (2001) Case-control study of parental age, parity and socioeconomic level in relation to childhood cancers. Int J Epidemiol 30(6):1428–1437CrossRefPubMedGoogle Scholar
  6. 6.
    Fretts RC, Schmittdiel J, McLean FH, Usher RH, Goldman MB (1995) Increased maternal age and the risk of fetal death. N Engl J Med 333(15):953–957CrossRefPubMedGoogle Scholar
  7. 7.
    Gaulden ME (1992) Maternal age effect: the enigma of Down syndrome and other trisomic conditions. Mutation Research/Reviews in Genetic Toxicology 296(1–2):69–88CrossRefGoogle Scholar
  8. 8.
    Gualco G, Klumb CE, Barber GN, Weiss LM, Bacchi CE (2010) Pediatric lymphomas in Brazil. Clinics (Sao Paulo) 65(12):1267–1278CrossRefGoogle Scholar
  9. 9.
    Johnson KJ, Carozza SE, Chow EJ, Fox EE, Horel S, McLaughlin CC, Spector LG (2009) Parental age and risk of childhood cancer: a pooled analysis. Epidemiology (Cambridge, Mass.) 20(4):475CrossRefGoogle Scholar
  10. 10.
    Jolly M, Sebire N, Harris J, Robinson S, Regan L (2000) The risks associated with pregnancy in women aged 35 years or older. Hum Reprod 15(11):2433–2437CrossRefPubMedGoogle Scholar
  11. 11.
    Kaatsch P (2010) Epidemiology of childhood cancer. Cancer Treat Rev 36(4):277–285CrossRefPubMedGoogle Scholar
  12. 12.
    Key TJA (1995) Hormones and cancer in humans. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 333(1):59–67CrossRefPubMedGoogle Scholar
  13. 13.
    Little J. 149 ed. Lyon; Oxford: International Agency for Research on Cancer; Distributed by Oxford University Press; 1999. Epidemiology of childhood cancerGoogle Scholar
  14. 14.
    Luke B, Brown MB (2007) Elevated risks of pregnancy complications and adverse outcomes with increasing maternal age. Hum Reprod 22(5):1264–1272CrossRefPubMedGoogle Scholar
  15. 15.
    MacMahon B, Newill VA (1962) Birth characteristics of children dying of malignant neoplasms. J Natl Cancer Inst 28(1):231–244PubMedGoogle Scholar
  16. 16.
    Office for National Statistics Social trends 29, 1999 Edition. The Stationery Office, LondonGoogle Scholar
  17. 17.
    Olshan AF, Smith J, Cook MN, Grufferman S, Pollock BH, Stram DO, Bondy ML (1999) Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. Am J Epidemiol 150(9):930–938CrossRefPubMedGoogle Scholar
  18. 18.
    Ries L. G., Smith M. A., Gurney J. G., Linet M., Tamra T., Young J. L., & Bunin G. (1999) Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995Google Scholar
  19. 19.
    Ross JA, Spector LG, Robison LL, Olshan AF (2005) Epidemiology of leukemia in children with Down syndrome. Pediatr Blood Cancer 44(1):8–12CrossRefPubMedGoogle Scholar
  20. 20.
    Samouhos E (1983) Chromosomes, cancer and radiosensitivity. Am J Clin Oncol 6(4):503–506CrossRefPubMedGoogle Scholar
  21. 21.
    Sandlund JT, Downing JR, Crist WM (1996) Non-Hodgkin's lymphoma in childhood. N Engl J Med 334(19):1238–1248CrossRefPubMedGoogle Scholar
  22. 22.
    Schüz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J (1999) Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 28(4):631–639CrossRefPubMedGoogle Scholar
  23. 23.
    Stark CR, Mantel N (1966) Effects of maternal age and birth order on the risk of mongolism and leukemia. J Natl Cancer Inst 37(5):687–698PubMedGoogle Scholar
  24. 24.
    Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh JW, Lacour B, Perkin M (2004) Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet 364(9451):2097–2105CrossRefPubMedGoogle Scholar
  25. 25.
    Steuerwald NM, Bermúdez MG, Wells D, Munné S, Cohen J (2007) Maternal age-related differential global expression profiles observed in human oocytes. Reprod BioMed Online 14(6):700–708CrossRefPubMedGoogle Scholar
  26. 26.
    Statistics TCBo. (2013) Israel in figures. http://www.cbs.gov.il/www/publications/isr_in_n15e.pdf. Accessed 25 May 2015
  27. 27.
    Troisi R, Potischman N, Roberts J, Siiteri P, Daftary A, Sims C, Hoover RN (2003) Associations of maternal and umbilical cord hormone concentrations with maternal, gestational and neonatal factors (United States). Cancer Causes Control 14(4):347–355CrossRefPubMedGoogle Scholar
  28. 28.
    Wainstock T, Walfisch A, Shoham-Vardi I, Segal I, Harlev A, Sergienko R, Sheiner E (2017) Fertility treatments and pediatric neoplasms of the offspring: results of a population-based cohort with a median follow-up of 10 years. Am J Obstet Gynecol 216(3):314–3e1CrossRefPubMedGoogle Scholar
  29. 29.
    Yaniv SS, Levy A, Wiznitzer A, Holcberg G, Mazor M, Sheiner E (2011) A significant linear association exists between advanced maternal age and adverse perinatal outcome. Arch Gynecol Obstet 283(4):755–759CrossRefGoogle Scholar
  30. 30.
    Yeazel MW, Ross JA, Buckley JD, Woods WG, Ruccione K, Robison LL (1997) High birth weight and risk of specific childhood cancers: a report from the Children’s Cancer Group. J Pediatr 131(5):671–677CrossRefPubMedGoogle Scholar
  31. 31.
    Yip BH, Pawitan Y, Czene K (2006) Parental age and risk of childhood cancers: a population-based cohort study from Sweden. Int J Epidemiol 35(6):1495–1503CrossRefPubMedGoogle Scholar
  32. 32.
    Yoon PW, Freeman SB, Sherman SL, Taft LF, Gu Y, Pettay D, Hassold TJ (1996) Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: a population-based study. Am J Hum Genet 58(3):628–633PubMedPubMedCentralGoogle Scholar
  33. 33.
    Yu H, Rohan T (2000) Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92(18):1472–1489CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Obstetrics and Gynecology, Soroka University Medical CenterBen-Gurion University of the NegevBeer-ShevaIsrael
  2. 2.Department of Public Health, Faculty of Health SciencesBen-Gurion University of the NegevBeer-ShevaIsrael
  3. 3.Department of Pediatric Hemato-Oncology, Soroka University Medical CenterBen-Gurion University of the NegevBeer-ShevaIsrael
  4. 4.Faculty of Health SciencesBen-Gurion University of the NegevBeer-ShevaIsrael

Personalised recommendations